Patents and the experimental space: social, legal and geographical dimensions of 3D bioprinting

References

• Abraham, J. 2009. “Sociology of Pharmaceuticals Development and Regulation: A Realistic Empirical Research Programme.” In Pharmaceuticals and Society: Critical Discourses and Debates, edited by S. J. Williams, J. Gabe, and P. Davis, 54–66. Oxford: Wiley-Blackwell.
   Google Scholar
• Abudayyeh, I., B. Gordon, M. M. Ansari, K. Jutzy, L. Stoletniy, and A. Hilliard. 2018. “A Practical Guide to Cardiovascular 3D Printing in Clinical Practice: Overview and Examples.” Journal of Interventional Cardiology 31: 375–383.
   PubMed Web of Science ®Google Scholar
• Adelman, D. E., and K. L. Deangelis. 2007. “Patent Metrics: The Mismeasure of Innovation in the Biotech Patent Debate.” Texas Law Review 85: 1677–1744.
   Web of Science ®Google Scholar
• Ahadian, S., and A. Khademhosseini. 2018. “A Perspective on 3D Bioprinting in Tissue Regeneration.” Bio-Design and Manufacturing 1: 157–160.
   PubMed Web of Science ®Google Scholar
• Arrow, K. J. 1962. “Economic Welfare and the Allocation of Resources for Invention.” In The Rate and Direction of Inventive Activity, edited by R. R. NELSON, 609–626. New York: Princeton University Press.
   Google Scholar
• Bauer, H.-K., M. Heller, M. Fink, D. Maresch, J. Gartner, U. M. Gassner, and B. Al-Nawas. 2016. “Social and Legal Frame Conditions for 3D (and) Bioprinting in Medicine.” International Journal of Computerized Dentistry 19: 293–299.
   PubMed Web of Science ®Google Scholar
• Bicudo, E. 2011. “‘Geographical Randomization’ and ‘Social Exploitation’ in Clinical Research: World Trials in Santiago, Chile.” Health & Place 17: 807–813.
   PubMed Web of Science ®Google Scholar
• Bicudo, E. 2014. Pharmaceutical Research, Democracy and Conspiracy: International Clinical Trials in Local Medical Institutions. London: Gower/Ashgate.
   Google Scholar
• Bicudo, E. 2018. “‘Big Data’ or ‘Big Knowledge’? Brazilian Genomics and the Process of Academic Marketization.” BioSocieties 13: 1–20.
   Web of Science ®Google Scholar
• Bouchard, R. 2012. Patently Innovative: How Pharmaceutical Firms Use Emerging Patent Law to Extend Monopolies on Blockbuster Drugs. Amsterdam: Elsevier Science.
   Google Scholar
• Brown, N., and M. Michael. 2003. “A Sociology of Expectations: Retrospecting Prospects and Prospecting Retrospects.” Technology Analysis & Strategic Management 15: 3–18.
   Web of Science ®Google Scholar
• Busfield, J. 2006. “Pills, Power, People: Sociological Understandings of the Pharmaceutical Industry.” Sociology – The Journal of the British Sociological Association 40: 297–314.
   Web of Science ®Google Scholar
• Castro, J. O., S. Ramesan, A. R. Rezk, and L. Y. Yeo. 2018. “Continuous Tuneable Droplet Ejection via Pulsed Surface Acoustic Wave Jetting.” Soft Matter 14: 5271–5277.
   Web of Science ®Google Scholar
• Davis, C., and J. Abraham. 2013. “Is There a Cure for Corporate Crime in the Drug Industry?” British Medical Journal 346: 1–2.
   Google Scholar
• Dixon-Woods, M., E. Angell, R. E. Ashcroft, and A. Bryman. 2007. “Written Work: The Social Functions of Research Ethics Committee Letters.” Social Science & Medicine 65: 792–802.
   PubMed Web of Science ®Google Scholar
• Faulkner, A. 2009. Medical Technology Into Healthcare and Society: A Sociology of Devices, Innovation and Governance. London: Palgrave.
   Google Scholar
• Faulkner, A. 2012. “Law’s Performativities: Shaping the Emergence of Regenerative Medicine Through European Union Legislation.” Social Studies of Science 42: 753–774.
   PubMed Web of Science ®Google Scholar
• Freeman, C. 1987. Technology and Economic Performance: Lessons From Japan. London: Pinter.
   Google Scholar
• Fromhold-Eisebith, M. 2007. “Bridging Scales in Innovation Policies: How to Link Regional, National and International Innovation Systems.” European Planning Studies 15: 217–233.
   Web of Science ®Google Scholar
• Garcia-Garcia, L. A., and M. Rodriguez-Salvador. 2018. “Uncovering 3D Bioprinting Research Trends: A Keyword Network Mapping Analysis.” International Journal of Bioprinting 4: 1–8.
   Web of Science ®Google Scholar
• Gardner, J., G. Samuel, and C. Williams. 2015. “Sociology of Low Expectations: Recalibration as Innovation Work in Biomedicine.” Science Technology and Human Values 40: 998–1021.
   PubMed Web of Science ®Google Scholar
• Graboswki, H. 2002. “Patents, Innovation and Access to New Pharmaceuticals.” Journal of International Economic Law 5: 849–860.
   Web of Science ®Google Scholar
• Habermas, J. 1996. Between Facts and Norms: Contributions to a Discourse Theory of Law and Democracy. Cambridge: MIT Press.
   Google Scholar
• Harrison, C. 2019. “Berkeley Strikes Back in CRISPR Patent Tussle.” Nature Biotechnology 37: 338–339.
   PubMed Web of Science ®Google Scholar
• Harvey, M., and A. Mcmeekin. 2005. “Brazilian Genomics and Bioinformatics: Instituting New Innovation Pathways in a Global Context.” Economy and Society 34: 634–658.
   Web of Science ®Google Scholar
• Heller, M. A., and R. S. Eisenberg. 1998. “Can Patents Deter Innovation? The Anticommons in Biomedical Research.” Science 280: 698–701.
   PubMed Web of Science ®Google Scholar
• Hirst, P. 1977. On Law and Ideology. London: Palgrave Macmillan.
   Google Scholar
• Hornick, J. F., and K. Rajan. 2016. “ The 3D Bioprinting Patent Landscape Takes Shape as IP Leaders Emerge.” 3D Printing Industry. http://3dprintingindustry.com/news/3d-bioprinting-patent-landscape-takes-shape-ip-leaders-emerge-84541/.
   Google Scholar
• Humphreys, S. 1985. “Law as Discourse.” History and Anthropology 1: 241–264.
   Google Scholar
• Kelly, E. 2018. “FDA Regulation of 3D-Printed Organs and Associated Ethical Challenges.” University of Pennsylvania Law Review 166: 515–545.
   Web of Science ®Google Scholar
• Kesselheim, A., and J. Avorn. 2009. “Using Patent Data to Assess the Value of Pharmaceutical Innovation.” Journal of Law Medicine & Ethics 37: 176–183.
   PubMed Web of Science ®Google Scholar
• Kumazawa, R. 2017. “Patenting in the Pharmaceutical Industry.” In Intellectual Property Rights, edited by S. L. Prabu and T. N. K. Suriyaprakasha, 23–38. London: IntechOpen.
   Google Scholar
• Laffont, J.-J., and J. Tirole. 1991. “The Politics of Government Decision-Making: A Theory of Regulatory Capture.” The Quarterly Journal of Economics 106: 1089–1127.
   Web of Science ®Google Scholar
• Lakoff, A. 2005. Pharmaceutical Reason: Knowledge and Value in Global Psychiatry. Cambridge: Cambridge University Press.
   Google Scholar
• Latour, B. 1987. Science in Action: How to Follow Scientists and Engineers Through Society. Cambridge: Harvard University Press.
   Google Scholar
• Levin, R. C., A. K. Klevorick, R. R. Nelson, and S. G. Winter. 1987. “Appropriating the Returns From Industrial Research and Development.” Brookings Papers on Economic Activity 3: 783–820.
   Google Scholar
• Levine, M. E., and J. L. Forrence. 1990. “Regulatory Capture, Public Interest, and the Public Agenda: Toward a Synthesis.” Journal of Law, Economics, and Organization 6: 167–198.
   Web of Science ®Google Scholar
• Li, P., and A. Faulkner. 2017. “3D Bioprinting Regulations: A UK/EU Perspective.” European Journal of Risk Regulation 8: 441–447.
   Web of Science ®Google Scholar
• Li, P., A. Faulkner, and N. Medcalf. 2020. “3D Bioprinting in a 2D Regulatory Landscape: Gaps, Uncertainties, and Problems.” Law Innovation and Technology 12: 1–29.
   Google Scholar
• Lim, D. 2018. “Disruption and Development: The Evolving CRISPR Patent and Technology Landscape.” Pharmaceutical Patent Analyst 7: 141–145.
   PubMed Web of Science ®Google Scholar
• Luhmann, N. 1972. A Sociological Theory of Law. London: Routledge & Kegal Paul.
   Google Scholar
• Ma, X., J. Liu, W. Zhu, M. Tang, N. Lawrence, C. Yu, M. Gou, and S. Chen. 2018. “3D Bioprinting of Functional Tissue Models for Personalized Drug Screening and in Vitro Disease Modeling.” Advanced Drug Delivery Reviews 132: 235–251.
   PubMed Web of Science ®Google Scholar
• Malerba, F. 2002. “Sectoral Systems of Innovation and Production.” Research Policy 31: 247–264.
   Web of Science ®Google Scholar
• Mansfield, E. 1986. “Patents and Innovation: An Empirical Study.” Management Science 32: 173–181.
   Web of Science ®Google Scholar
• Mironov, V., V. Kasyanov, C. Drake, and R. R. Markwald. 2008. “Organ Printing: Promises and Challenges.” Regenerative Medicine 3: 93–103.
   PubMed Web of Science ®Google Scholar
• Nelson, R. R. 1993. National Innovation Systems. A Comparative Analysis. New York: Oxford University Press.
   Google Scholar
• Nicol, D. 2009. “Strong Patent Rights, Weak Patent Standards and Innovation in Biomedicine.” In Intellectual Property Policy Reform: Fostering Innovation and Development, edited by C. Arup and W. Van Caenegem, 55–79. Cheltenham: Edward Elgar.
   Google Scholar
• Nordhaus, W. D. 1969. Invention, Growth, and Welfare: A Theoretical Treatment of Technological Change. Cambridge: MIT Press.
   Google Scholar
• Organisation for Economic Cooperation and Development (OECD). 1997. National Innovation Systems. Paris: Organisation for Economic Cooperation and Development (OECD). http://www.oecd.org/science/inno/2101733.pdf.
   Google Scholar
• Patel, P., and K. Pavitt. 1994. “The Nature and Economic Importance of National Innovation Systems.” STI Review 14: 9–32.
   Google Scholar
• Peltzman, S. 1976. “Toward a More General Theory of Regulation.” The Journal of Law and Economics 19: 211–240.
   Web of Science ®Google Scholar
• Petryna, A. 2009. When Experiments Travel: Clinical Trials and the Global Search for Human Subjects. Princeton/Oxford: Princeton University Press.
   Google Scholar
• Prior, L. 2008. “Repositioning Documents in Social Research.” Sociology 42: 821–836.
   Google Scholar
• Qian, Y. 2007. “Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-Country Analysis of Pharmaceutical Patent Protection, 1978–2002.” Review of Economics and Statistics 89: 436–453.
   Web of Science ®Google Scholar
• Rajan, K. S. 2003. “Genomics Capital: Public Cultures and Market Logics of Corporate Biotechnology.” Science as Culture 12: 87–121.
   PubMedGoogle Scholar
• Roberts, M., I. B. Wall, I. Bingham, D. Icely, B. Reeve, K. Bure, A. French, and D. A. Brindley. 2014. “The Global Intellectual Property Landscape of Induced Pluripotent Stem Cell Technologies.” Nature Biotechnology 32: 742–748.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Salvador, M., R. M. Rio-Belver, and G. Garechana-Anacabe. 2017. “Scientometric and Patentometric Analyses to Determine the Knowledge Landscape in Innovative Technologies: The Case of 3D Bioprinting.” PLoS One 12: 1–22.
   Web of Science ®Google Scholar
• Rosemann, A., and N. Chaisinthop. 2016. “The Pluralization of the International: Resistance and Alter-Standardization in Regenerative Stem Cell Medicine.” Social Studies of Science 46: 112–139.
   PubMed Web of Science ®Google Scholar
• Rosemann, A., F. Vasen, and G. Bortz. 2019. “Global Diversification in Medicine Regulation: Insights From Regenerative Stem Cell Medicine.” Science as Culture 28: 223–249.
   Web of Science ®Google Scholar
• Salter, B., Y. Zhou, S. Datta, and C. Salter. 2016. “Bioinformatics and the Politics of Innovation in the Life Sciences: Science and the State in the United Kingdom, China, and India.” Science, Technology & Human Values 41: 793–826.
   PubMed Web of Science ®Google Scholar
• Scherer, F. M. 1972. “Nordhaus’s Theory of Optimal Patent Life: A Geometric Reinterpretation.” The American Economic Review 62: 422–427.
   Web of Science ®Google Scholar
• Schwarte, L. 2005. “Anatomical Theatre as Experimental Space.” In Collection – Laboratory – Theatre: Scenes of Knowledge in the 17th Century, edited by H. Schramm, L. Scwarte, and J. Lazardzig, 75–102. Berlin: Walter de Gruyter.
   Google Scholar
• Shah, S. 2006. The Body Hunters: Testing New Drugs on the World’s Poorest Patients. New York: New Press.
   Google Scholar
• Stigler, G. J. 1971. “The Theory of Economic Regulation.” The Bell Journal of Economics and Management Science 2: 3–21.
   Google Scholar
• Tang, W. 2013. “Revitalizing the Patent System to Incentivize Pharmaceutical Innovation: The Potential of Claims with Means-Plus-Functions Clauses.” Duke Law Journal 62: 1069–1108.
   PubMed Web of Science ®Google Scholar
• Taylor, C. T., and Z. A. Silberston. 1973. The Economic Impact of the Patent System. Cambridge: Cambridge University Press.
   Google Scholar
• Van Lente, H. 2012. “Navigating Foresight in a Sea of Expectations: Lessons From the Sociology of Expectations.” Technology Analysis & Strategic Management 24: 769–782.
   Web of Science ®Google Scholar
• Wittgenstein, L. 1922. Tractatus Logico-Philosophicus. London: Kegan Paul.
   Google Scholar
• Yoo, S.-S. 2015. “3D-printed Biological Organs: Medical Potential and Patenting Opportunity.” Expert Opinion on Therapeutic Patents 25: 507–511.
   PubMed Web of Science ®Google Scholar